How to compare material contracts in a diligence table for Series A Financing Rounds

Compare material contracts by translating each complete agreement package into consistent, source-linked fields, then testing the differences against the proposed Series A financing. For company counsel, the deliverable is a diligence table separating verified terms, missing evidence, financing-sensitive restrictions, and operating risks requiring disclosure or action. Start with the proposed purchase agreement’s representations and the company’s dependencies—not a generic dollar cutoff. Give each unresolved issue an owner, a decision date, and a proposed disposition before circulating the table.

When to use this workflow

Use this workflow when a company receives an investor diligence request, prepares disclosure schedules, or assesses whether existing commercial commitments affect its Series A. It serves company counsel, in-house legal teams, and finance and operating personnel supplying evidence.

Compare customer, supplier, IP, distribution, debt, and other material operating agreements. This table supports, but does not replace, capitalization diligence or a closing checklist. The scope assumes a U.S. private-company financing involving a Delaware corporation. Contract interpretation depends on the actual language, governing law, facts, and transaction structure; Delaware incorporation does not make Delaware law govern every operating agreement.

Begin before disclosure schedules are settled. An overlooked lender covenant or customer amendment can change both the comparison and the response to investors.

What you need

Collect the proposed purchase agreement, disclosure-schedule instructions, investor request list, term sheet, and current financing structure. Include expected voting changes, debt conversions, and related restructuring needed to evaluate contractual triggers.

For operating contracts, request:

• Executed agreements, amendments, schedules, order forms, incorporated terms, side letters, and existing consents or waivers.
• An index identifying the contracting entity, counterparty, execution status, document date, and business owner.
• Finance records showing revenue, spend, outstanding debt, and remaining minimum commitments, with measurement periods.
• Business-owner explanations of critical dependencies, replacement options, disputes, threatened termination, and undocumented arrangements.

Separate unsigned drafts from operative documents. For incorporated online terms, identify the applicable version rather than assuming current website text controls.

Reconcile the investor’s requested population with the proposed representations. Add low-value agreements carrying significant IP, exclusivity, security, or operational consequences. Record missing, withheld, and not-applicable items separately.

Use the template

The companion template is Series A Financing Rounds — Material contracts comparison. Copy this table into your working document or spreadsheet. Use one row per agreement package initially; add linked issue rows for independently actionable problems.

Assign a stable package identifier, such as MC-014, and separate document IDs to its components. In Evidence, record document ID, version, section, and PDF page so another lawyer can reproduce the finding.

In Compared terms, follow the same sequence: assignment; change of control; financing restrictions; termination and renewal; exclusivity; IP; indemnity; liability limitations. Use separate columns in the working spreadsheet if useful, retaining clause references.

Value / dependency distinguishes historical revenue or spend from remaining commitments. Financing effect applies the transaction facts rather than repeating the clause. Gap / priority identifies uncertainty and explains consequences. Action / owner / date assigns the next step. Disposition records whether the issue is cleared, open, proposed for disclosure, or awaiting remediation. Link any clearance to its evidence; these entries are working judgments, not certifications.

Step by step

1. Define the comparison population from the financing documents

Read the proposed material-contract representation and disclosure qualifications before setting inclusion criteria. Identify monetary thresholds, aggregation rules, lookback periods, categories, and exceptions actually used in the draft.

For illustration, RPX’s historical Series A and A-1 purchase agreement §2.12(b) addressed obligations or payments above $10,000 alongside material IP licenses, product restrictions, and IP indemnities, with exceptions. Section 2.12(d) aggregated arrangements involving the same person or certain affiliates. These are agreement-specific choices, not general Series A thresholds. (SEC-filed RPX agreement, §§2.12(b), (d))

Apply the actual draft’s criteria and add operationally critical agreements below its threshold. Record inclusion reasons and periods in Value / dependency. Keep an exclusion log so counsel can explain why other agreements were omitted.

2. Assemble and reconcile each agreement package

Match base agreements to amendments, orders, schedules, renewals, and relevant correspondence. Confirm the contracting entity, signatures, effective date, and evidence of replacement or termination. Ask the business owner whether another document changes the terms.

Do not treat the newest upload as controlling merely because its upload date is later. Examine amendment precedence and identify the provisions changed.

Record the reviewed package in ID / package and Evidence. Make missing-document requests specific: “Executed amendment referenced in order form not supplied,” rather than “documents incomplete.” Put the request and affected conclusions in Gap / priority; keep those conclusions unresolved until the evidence is assessed.

3. Extract terms consistently without flattening distinctions

For each topic, capture the obligation, beneficiary, trigger, exceptions, duration, and relevant definitions. Separate assignment restrictions from change-of-control provisions. A restriction on transferring the agreement should not silently become a conclusion about issuing preferred shares.

Distinguish termination for convenience from termination for breach. Preserve renewal notice periods, delivery methods, and triggering dates. For IP, distinguish ownership, licenses, improvements, customer deliverables, and surviving rights. For indemnity and liability caps, retain exclusions, special caps, and the obligations covered.

Record concise findings in Compared terms, supported by Evidence citations. Use “not located in reviewed package” where appropriate. An unsuccessful extraction is not proof that no obligation exists. For a linked issue row, identify the parent package rather than duplicating its entire summary.

4. Test restrictions against the actual Series A structure

Apply financing facts to the extracted language. Does a clause address securities issuance, voting-control changes, investor identity, new indebtedness, or conversion of existing debt? Do definitions, affiliate exceptions, notice requirements, or consent conditions alter the assessment?

Separate interpretation from factual inputs. If voting control matters, obtain the pre- and post-financing capitalization analysis and relevant voting arrangements. Do not infer control from the round’s name or investment amount. If the transaction includes restructuring, test that step separately from the stock issuance.

Record the supported conclusion in Financing effect and missing inputs in Gap / priority. Where consent may be needed, identify the counterparty, required form, and evidence of authority. Route outreach through counsel and the relationship owner rather than treating a preliminary table entry as authorization to contact the counterparty.

5. Compare business exposure and set priorities

Read across rows for concentrations and mismatches. A small infrastructure license can outrank a large customer agreement if the company cannot operate without it. A favorable liability cap in one agreement does not offset an uncapped obligation elsewhere.

Separate financing obstacles, continuing operating risks, and evidence gaps. Explain priority through consequences: uncertain permission to complete the financing, possible loss of technology rights, a near-term termination option, or unsupported disclosure language.

Record that rationale in Gap / priority and assign an owner and decision date in Action / owner / date. Work backward from schedule review and expected signing, allowing time for evidence collection or negotiations. A missing document can justify urgent collection without establishing a legal breach.

6. Translate findings into disclosure and resolution decisions

For each significant issue, choose the next response: collect evidence, obtain interpretive analysis, seek business acceptance, propose disclosure, or obtain consent or an amendment. Investor disclosure and counterparty clearance answer different questions; record each separately.

Check the purchase agreement’s representation and closing-condition mechanics. RPX’s §§4.1–4.3 connect representations, read with its Schedule of Exceptions, to performance and an officer’s certificate. Section 4 applies conditions at each closing and makes waiver ineffective against a nonconsenting investor. That wording illustrates why clearance must identify the applicable closing and authority, not assume one resolution covers every closing. (SEC-filed RPX agreement, §4)

Record the proposed Disposition, linking the relevant draft schedule or separate closing issue. Mark a proposed consent as pending until the required evidence is received and checked.

7. Verify and prepare the circulation version

Have a lawyer check source language for financing-sensitive conclusions and high-priority exceptions. Ask business owners to confirm operational facts, not legal conclusions. Reconcile amendments and draft changes against the table; retain its review date and source versions.

Before sharing, assess confidentiality restrictions, intended recipients, and internal legal analysis. One SEC-filed investment agreement’s Exhibit B §4.1 provides information rights for defined Major Purchasers and separately limits confidential-information access and competitor rights. It illustrates recipient-specific drafting, not permission to disclose this company’s contracts. (SEC-filed investment agreement, Exhibit B §4.1)

Record the approved Disposition and clearance evidence. Keep unresolved rows visible with owners. Prepare an appropriate factual circulation version without assuming every internal note belongs in investor diligence materials.

Worked example

Fictional scenario: Cedar Lantern Robotics, Inc. is preparing a $9 million Series A. The investor requests material commercial agreements; disclosure schedules remain under review. Finance provides revenue and spend figures, but final voting capitalization analysis is unavailable. The disclosure-schedule review milestone precedes signing review.

All parties, documents, amounts, and provisions below are invented. Counsel reviews three packages; the table does not assume the content of missing evidence.

The comparison changes three decisions. MC-01 requires voting facts before a consent conclusion. MC-02 takes priority despite its smaller fee because deployment rights affect the product; neither disclosure nor licensing clearance can rest on an imagined Schedule B. MC-03 corrects the base-agreement summary: the amendment removes the expected convenience exit, increasing the significance of the purchase commitment. Procurement must confirm demand while finance verifies the remaining amount.

Common mistakes

• Using annual value as the only filter. Include IP, exclusivity, debt, and critical dependencies relevant to the representations and business.
• Combining assignment and control restrictions. Extract each separately and apply the financing facts to its definitions and exceptions.
• Ignoring amendments. Reconcile the package before comparing exit rights, liability allocation, or commitments.
• Treating disclosure as clearance. Track investor disclosure, counterparty consent, and business acceptance as separate decisions with separate evidence.
• Turning blanks into “none.” Distinguish missing documents, unreviewed text, provisions not located, and supported negative conclusions.

Final quality check

• The population reconciles to investor requests, proposed representations, and operating dependencies.
• Packages have stable IDs, execution status, and linked amendments.
• Material findings cite operative clauses and pages checked against the source.
• Assignment, control, and express financing triggers remain separate.
• Monetary fields identify periods and distinguish historical figures from commitments.
• Priorities state consequences and distinguish uncertainty from established risk.
• Open issues have owners and decision dates; completed items have clearance evidence.
• The circulation version reflects confidentiality review and separates internal advice from approved disclosure.

Complete the workflow with DecoverAI

DecoverAI is the Legal Intelligence Platform for litigation and transactions. Its due diligence capabilities include bulk document classification to organize diligence and prioritize human review; tabular review supports work across multiple documents. For focused contract review in Word, choose the company as represented party and provide deal-specific instructions. Findings quote clauses, locate text, rank severity, and identify missing language as not present. Counsel must verify completeness and conclusions before using findings in the table. To assess this workflow for your team, book a demo.

Frequently asked questions

Should every customer contract receive a separate row?

Use separate rows when terms, dependencies, or disclosure treatment differ materially. For repeated forms, identify the reviewed population, form version, and exceptions. Check order forms for changes rather than assuming they contain only commercial details.

What if the Series A does not change voting control?

Continue checking express financing, investor-identity, debt, notice, and assignment provisions. A negative control analysis resolves only the provision tested. Record the facts and definition supporting that conclusion so later structural changes can be assessed.

Can the table replace disclosure schedules?

No. It supplies evidence and proposed treatment. Map findings to the actual representations, schedule instructions, and negotiated qualifications. Keep the table’s source references even when the approved schedule uses a shorter description.

How should missing amendments be shown?

Name the amendment, cite where it is referenced, and identify dependent conclusions. Assign collection to an owner and date. Do not clear the affected issue while material evidence remains unresolved; expressly assign any remaining uncertainty for decision.

Sources

• RPX Series A and A-1 Preferred Stock Purchase Agreement, §§2.12(b), (d), 4.
• Series A Preferred Stock Investment Agreement, Exhibit B §4.1.

Scope: General company-side workflow guidance using the supplied research cutoff of October 13, 2026. Filed agreements illustrate specific drafting choices, not universal requirements or market standards.

This guide is general information about legal workflows, not legal advice for any matter. It was drafted and reviewed with AI assistance. The worked example is fictional. Contract rights and procedure depend on the governing law, the actual wording, and the facts, so check the cited sources and the rules that apply in your jurisdiction before relying on it.